Publications

Selected Literature

Linke M, Pham HT, Katholnig K, Schnöller T, Miller A, Demel F, Schütz B, Rosner M, Kovacic B, Sukhbaatar N, Niederreiter B, Blüml S, Kuess P, Sexl V, Müller M, Mikula M, Weckwerth W, Haschemi A, Susani M, Hengstschläger M, Gambello MJ, Weichhart T. 2017. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat Immunol 18:293–302. https://doi.org/10.1038/ni.3655 PMID:28092373

 

Sukhbaatar N, Hengstschläger M, Weichhart T. 2016. mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function. Trends Immunol 37:778–789. https://doi.org/10.1016/j.it.2016.08.009 PMID:27614799

 

Weichhart T, Hengstschläger M, Linke M. 2015. Regulation of innate immune cell function by mTOR. Nat Rev Immunol 15:599–614. https://doi.org/10.1038/nri3901 PMID:26403194

 

Fritsch SD, Weichhart T. 2016. Effects of Interferons and Viruses on Metabolism. Front Immunol 7:630. https://doi.org/10.3389/fimmu.2016.00630 PMID:28066439

 

Üstün S, Lassnig C, Preitschopf A, Mikula M, Müller M, Hengstschläger M, Weichhart T. 2015. Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transpl Immunol 33:45–50. https://doi.org/10.1016/j.trim.2015.06.001 PMID:26073719

 

Katholnig K, Kaltenecker CC, Hayakawa H, Rosner M, Lassnig C, Zlabinger GJ, Gaestel M, Müller M, Hengstschläger M, Hörl WH, Park JM, Säemann MD, Weichhart T. 2013. p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J Immunol 190:1519–1527. https://doi.org/10.4049/jimmunol.1202683 PMID:23315073

 

Kopecky C, Genser B, Drechsler C, Krane V, Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD, Weichhart T. 2015. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. Clin J Am Soc Nephrol 10:224–231. https://doi.org/10.2215/CJN.06560714 PMID:25424990

 


Peer reviewed original publications

Karonitsch T, Kandasamy RK, Kartnig F, Herdy B, Dalwigk K, Niederreiter B, Holinka J, Sevelda F, Windhager R, Bilban M, Weichhart T, Säemann M, Pap T, Steiner G, Smolen JS, Kiener HP, Superti-Furga G. 2018. mTOR Senses Environmental Cues to Shape the Fibroblast-like Synoviocyte Response to Inflammation. Cell Rep 23:2157-2167. https://doi.org/10.1016/j.celrep.2018.04.044 PMID:29768212

 

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France). 2018. Whole exome sequencing in three families segregating a pediatric case of sarcoidosis. BMC Med Genomics 11:23. https://doi.org/10.1186/s12920-018-0338-x PMID:29510755

 

Kopecky C, Michlits G, Säemann MD, Weichhart T. 2017. Pro- versus Anti-inflammatory Actions of HDLs in Innate Immunity. Cell Metab 26:2-3. https://doi.org/10.1016/j.cmet.2017.04.007 PMID:28648980

 

Vijayan V, Srinu T, Karnati S, Garikapati V, Linke M, Kamalyan L, Mali SR, Sudan K, Kollas A, Schmid T, Schulz S, Spengler B, Weichhart T, Immenschuh S, Baumgart-Vogt E. 2017. A New Immunomodulatory Role for Peroxisomes in Macrophages Activated by the TLR4 Ligand Lipopolysaccharide. J Immunol 198:2414–2425. https://doi.org/10.4049/jimmunol.1601596 PMID:28179495

 

Kopecky C, Ebtehaj S, Genser B, Drechsler C, Krane V, Antlanger M, Kovarik JJ, Kaltenecker CC, Parvizi M, Wanner C, Weichhart T, Säemann MD, Tietge UJ. 2017. HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients. J Am Soc Nephrol 28:769–775. https://doi.org/10.1681/ASN.2016030262 PMID:27612996

 

Linke M, Pham HT, Katholnig K, Schnöller T, Miller A, Demel F, Schütz B, Rosner M, Kovacic B, Sukhbaatar N, Niederreiter B, Blüml S, Kuess P, Sexl V, Müller M, Mikula M, Weckwerth W, Haschemi A, Susani M, Hengstschläger M, Gambello MJ, Weichhart T. 2017. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat Immunol 18:293–302. https://doi.org/10.1038/ni.3655 PMID:28092373

 

Genser B, Fischer JE, Figueiredo CA, Alcântara-Neves N, Barreto ML, Cooper PJ, Amorim LD, Saemann MD, Weichhart T, Rodrigues LC. 2016. Applied immuno-epidemiological research: an approach for integrating existing knowledge into the statistical analysis of multiple immune markers. BMC Immunol 17:11. https://doi.org/10.1186/s12865-016-0149-9 PMID:27206492

 

Üstün S, Lassnig C, Preitschopf A, Mikula M, Müller M, Hengstschläger M, Weichhart T. 2015. Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transpl Immunol 33:45–50. https://doi.org/10.1016/j.trim.2015.06.001 PMID:26073719

 

Kopecky C, Genser B, Drechsler C, Krane V, Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD, Weichhart T. 2015. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. Clin J Am Soc Nephrol 10:224–231. https://doi.org/10.2215/CJN.06560714 PMID:25424990

 

Preitschopf A, Li K, Schörghofer D, Kinslechner K, Schütz B, Thi Thanh Pham H, Rosner M, Joo GJ, Röhrl C, Weichhart T, Stangl H, Lubec G, Hengstschläger M, Mikula M. 2014. mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. PLoS One 9:e107004. https://doi.org/10.1371/journal.pone.0107004 PMID:25221943

 

Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD. 2015. Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties. J Am Soc Nephrol 26:565-75.https://doi.org/10.1681/ASN.2013111219 PMID:25071090

 

Fruhwürth S, Krieger S, Winter K, Rosner M, Mikula M, Weichhart T, Bittman R, Hengstschläger M, Stangl H. 2014. Inhibition of mTOR Down-regulates Scavenger Receptor, Class B, Type I (SR-BI) Expression, Reduces Endothelial Cell Migration and Impairs Nitric Oxide Production. Biochim Biophys Acta 1841:944-53. https://doi.org/10.1016/j.bbalip.2014.03.014 PMID:24713582

 

Haidinger M, Werzowa J, Kain R, Antlanger M, Hecking M, Pfaffenberger S, Mascherbauer J, Gremmel T, Gilbertson JA, Rowczenio D, Weichhart T, Kopecky C, Hörl WH, Hawkins PN, Säemann MD. 2013. Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature. Amyloid 20:72–79. https://doi.org/10.3109/13506129.2013.781998 PMID:23551149

 

Katholnig K, Kaltenecker CC, Hayakawa H, Rosner M, Lassnig C, Zlabinger GJ, Gaestel M, Müller M, Hengstschläger M, Hörl WH, Park JM, Säemann MD, Weichhart T. 2013. p38α senses environmental stress to control innate immune responses via mTOR. J Immunol 190:1519–1527. https://doi.org/10.4049/jimmunol.1202683 PMID:23315073

 

Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, Höfler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L. 2012. PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med 18:1699–1704. https://doi.org/10.1038/nm.2966 PMID:23064464

 

Hecking M, Antlanger M, Winnicki W, Reiter T, Werzowa J, Haidinger M, Weichhart T, Polaschegg HD, Josten P, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Hörl WH, Sunder-Plassmann G, Säemann MD. 2012. Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials 13:79. https://doi.org/10.1186/1745-6215-13-79 PMID:22682149

 

Poglitsch M, Weichhart T, Hecking M, Werzowa J, Katholnig K, Antlanger M, Krmpotic A, Jonjic S, Hörl WH, Zlabinger GJ, Puchhammer E, Säemann MD. 2012. CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. Am J Transplant 12:1458–1468. https://doi.org/10.1111/j.1600-6143.2012.04002.x PMID:22390651

 

Weichhart T, Kopecky C, Kubicek M, Haidinger M, Döller D, Katholnig K, Suarna C, Eller P, Tölle M, Gerner C, Zlabinger GJ, van der Giet M, Hörl WH, Stocker R, Säemann MD. 2012. Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol 23:934–947. https://doi.org/10.1681/ASN.2011070668 PMID:22282592

 

Atamaniuk J, Kopecky C, Skoupy S, Säemann MD, Weichhart T. 2012. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 27:902–905. https://doi.org/10.1093/ndt/gfr695 PMID:22167588

 

Poglitsch M, Katholnig K, Säemann MD, Weichhart T. 2011. Rapid isolation of nuclei from living immune cells by a single centrifugation through a multifunctional lysis gradient. J Immunol Methods 373:167–173. https://doi.org/10.1016/j.jim.2011.08.012 PMID:21889513

 

Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, Rosner M, Zlabinger GJ, Hengstschläger M, Müller M, Hörl WH, Säemann MD. 2011. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood 117:4273–4283. https://doi.org/10.1182/blood-2010-09-310888 PMID:21368289

 

Haidinger M, Werzowa J, Voigt HC, Pleiner J, Stemer G, Hecking M, Döller D, Hörl WH, Weichhart T, Säemann MD. 2010. A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation. Trials 11:91. https://doi.org/10.1186/1745-6215-11-91 PMID:20925938

 

Haidinger M, Poglitsch M, Geyeregger R, Kasturi S, Zeyda M, Zlabinger GJ, Pulendran B, Hörl WH, Säemann MD, Weichhart T. 2010. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol 185:3919–3931. https://doi.org/10.4049/jimmunol.1000296 PMID:20805416

 

Wahrmann M, Haidinger M, Körmöczi GF, Weichhart T, Säemann MD, Geyeregger R, Kikić Z, Prikoszovich T, Drach J, Böhmig GA. 2010. Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates. Transplantation 89:1385–1390. https://doi.org/10.1097/TP.0b013e3181d9e1c0 PMID:20335829

 

Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Säemann MD, Geyeregger R, Schlederer M, Kenner L, Stulnig TM. 2010. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59:935–946. https://doi.org/10.2337/db09-0404 PMID:20107108

 

Haidinger M, Hecking M, Weichhart T, Poglitsch M, Enkner W, Vonbank K, Prayer D, Geusau A, Oberbauer R, Zlabinger GJ, Soleiman A, Hörl WH, Säemann MD. 2010. Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int 23:777–785. https://doi.org/10.1111/j.1432-2277.2009.01041.x PMID:20070623

 

Weichhart T, Brandt O, Lassnig C, Müller M, Hörl WH, Stingl G, Säemann MD. 2010. The anti-inflammatory potency of dexamethasone is determined by the route of application in vivo. Immunol Lett 129:50–52. https://doi.org/10.1016/j.imlet.2009.12.025 PMID:20060857

 

Haidinger M, Hecking M, Memarsadeghi M, Weichhart T, Werzowa J, Hörl WH, Säemann MD. 2009. Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept. Transpl Infect Dis 11:171–174. https://doi.org/10.1111/j.1399-3062.2009.00366.x PMID:19210692

 

Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhlmeier KM, Kolbe T, Stulnig TM, Hörl WH, Hengstschläger M, Müller M, Säemann MD. 2008. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29:565–577. https://doi.org/10.1016/j.immuni.2008.08.012 PMID:18848473

 

Weichhart T, Werzowa J, Hörl WH, Säemann MD. 2008. Biological action of rapamycin in renal transplantation. Am J Kidney Dis 51:531, author reply 531–532. https://doi.org/10.1053/j.ajkd.2007.09.027 PMID:18295073

 

Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM. 2008. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149:1350–1357. https://doi.org/10.1210/en.2007-1312 PMID:18048491

 

Pfistershammer K, Klauser C, Leitner J, Stöckl J, Majdic O, Weichhart T, Sobanov Y, Bochkov V, Säemann M, Zlabinger G, Steinberger P. 2008. Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein. J Leukoc Biol 83:131–138. https://doi.org/10.1189/jlb.0407231 PMID:17928461

 

Haidinger M, Geyeregger R, Poglitsch M, Weichhart T, Zeyda M, Vodenik B, Stulnig TM, Böhmig GA, Hörl WH, Säemann MD. 2007. Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation. Transplantation 84:117–121. https://doi.org/10.1097/01.tp.0000266677.45428.80 PMID:17627247

 

Bobacz K, Sunk IG, Amoyo L, Akira S, Weichhart T, Säemann MD, Smolen JS. 2007. Toll-like receptors and chondrocytes: the LPS induced decrease in cartilage mytrix synthesis is dependent on the presence of Toll-like receptor-4 and is antagonized by bone morphogenetic protein-7. Arthritis Rheum 56:1880–1893. https://doi.org/10.1002/art.22637 PMID:17530716

 

Huber J, Löffler M, Bilban M, Reimers M, Kadl A, Todoric J, Zeyda M, Geyeregger R, Schreiner M, Weichhart T, Leitinger N, Waldhäusl W, Stulnig TM. 2007. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes 31:1004–1013. https://doi.org/10.1038/sj.ijo.0803511 PMID:17130847

 

Zeyda M, Geyeregger R, Poglitsch M, Weichhart T, Zlabinger GJ, Koyasu S, Hörl WH, Stulnig TM, Watschinger B, Säemann MD. 2007. Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formation. J Leukoc Biol 81:319–327. https://doi.org/10.1189/jlb.0606378 PMID:17038582

 

Säemann MD, Weichhart T, Zeyda M, Staffler G, Schunn M, Stuhlmeier KM, Sobanov Y, Stulnig TM, Akira S, von Gabain A, von Ahsen U, Hörl WH, Zlabinger GJ. 2005. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115:468–475. https://doi.org/10.1172/JCI200522720 PMID:15650774

 

Weichhart T, Horky M, Söllner J, Gangl S, Henics T, Nagy E, Meinke A, von Gabain A, Fraser CM, Gill SR, Hafner M, von Ahsen U. 2003. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun 71:4633–4641. https://doi.org/10.1128/IAI.71.8.4633-4641.2003 PMID:12874343

 


Reviews

Sukhbaatar N, Weichhart T. 2018. Iron Regulation: Macrophages in Control. Pharmaceuticals (Basel)  14;11(4). https://doi.org/10.3390/ph11040137 PMID:30558109

 

Weichhart T. 2018. mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review. Gerontology  64:127-134. https://doi.org/10.1159/000484629 PMID:29190625

 

Linke M, Fritsch SD, Sukhbaatar N, Hengstschläger M, Weichhart T. 2017. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett 591:3089–3103. https://doi.org/10.1002/1873-3468.12711 PMID:28600802

 

Fritsch S, Weichhart T. 2016. Effects of interferons and viruses on metabolism, Frontiers Immunol 7:630. https://doi.org/10.3389/fimmu.2016.00630 PMID:28066439

 

Sukhbaatar N, Hengstschläger M, Weichhart T. 2016. mTOR-mediated regulation of dendritic cell differentiation and function, Trends Immunol 37:778-789. https://doi.org/10.1016/j.it.2016.08.009 PMID:27614799

 

Weichhart T, Hengstschläger M, Linke M. 2015. Regulation of innate immune cell function by mTOR. Nat Rev Immunol 15:599–614. https://doi.org/10.1038/nri3901 PMID:26403194

 

Duran I, Goebell PJ, Papazisis K, Ravaud A, Weichhart T, Rodriguez-Portal JA, Budde K. 2014. Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms. Expert Opin Drug Saf 13:361–372. https://doi.org/10.1517/14740338.2014.888056 PMID:24517115

 

Katholnig K, Linke M, Pham H, Hengstschläger M, Weichhart T. 2013. Immune responses of macrophages and dendritic cells regulated by mTOR signalling. Biochem Soc Trans 41:927–933. https://doi.org/10.1042/BST20130032 PMID:23863158

 

Haidinger M, Werzowa J, Weichhart T, Säemann MD. 2011. Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stone. Transplant Rev (Orlando) 25:145–153. https://doi.org/10.1016/j.trre.2010.11.001 PMID:21419611

 

Säemann MD, Poglitsch M, Kopecky C, Haidinger M, Hörl WH, Weichhart T. 2010. The versatility of HDL: a crucial anti-inflammatory regulator. Eur J Clin Invest 40:1131–1143. https://doi.org/10.1111/j.1365-2362.2010.02361.x PMID:20695882

 

Säemann MD, Haidinger M, Hecking M, Hörl WH, Weichhart T. 2009. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 9:2655–2661. https://doi.org/10.1111/j.1600-6143.2009.02832.x PMID:19788500

 

Weichhart T, Säemann MD. 2009. The multiple facets of mTOR in immunity. Trends Immunol 30:218–226. https://doi.org/10.1016/j.it.2009.02.002 PMID:19362054

 

Weichhart T, Säemann MD. 2008. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 67(Suppl 3):iii70–iii74. https://doi.org/10.1136/ard.2008.098459 PMID:19022819

 

Weichhart T, Haidinger M, Hörl WH, Säemann MD. 2008. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest 38(Suppl 2):29–38. https://doi.org/10.1111/j.1365-2362.2008.02006.x PMID:18826479

 

Säemann MD, Hörl WH, Weichhart T. 2007. Toll-like Rezeptoren und Integrine als Determinanten der Pathogenese des Harnwegsinfekts, Nephro-News 3/07.

 

Säemann MD, Weichhart T. 2006. Die Bedeutung des unspezifischen Immunsystems für die Nierentransplantation, Nephro-News 3/06.

 

Säemann MD, Weichhart T. 2005. New insights into the pathogenesis of urinary tract infection. Dtsch Med Wochenschr 130:2031–2034. https://doi.org/10.1055/s-2005-872625 PMID:16143935

 

Weichhart T, Zlabinger GJ, Säemann MD. 2005. The multiple functions of Tamm-Horsfall protein in human health and disease: a mystery clears up. Wien Klin Wochenschr 117:316–322. https://doi.org/10.1007/s00508-005-0353-8 PMID:15989109

 

Säemann MD, Weichhart T, Hörl WH, Zlabinger GJ. 2005. Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Invest 35:227–235. https://doi.org/10.1111/j.1365-2362.2005.01483.x PMID:15816991

 


Invited Editorials/Comments

Sellares J,  Strambu I,  Crouser ED,  Freudenberg MA,  Gulati M,  Hart S,  Herzog E,  Kolb M,  Weichhart T,  Drake WP,  Spitzer G,  Singh N,  Culver DA. 2018. New advances in the development of sarcoidosis models: A synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research. Sarcoidosis Vasc Diffuse Lung Dis 35 (1) 2-4. http://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/7032

 

Wilson JL, Weichhart T. 2018. TORching a semaphore for alternative macrophage activation. Nat Immunol 19:512-514 https://doi.org/10.1038/s41590-018-0117-z PMID:29777214

 

Kopecky C, Weichhart T, Säemann MD. 2015. HDL cholesterol efflux capacity and cardiovascular events. N Engl J Med 372:1869–1872. https://doi.org/10.1056/NEJMc1503139 PMID:25946299

 

Weichhart T, Säemann MD. 2010. Sirolimus and kidney transplantation: unraveling an inflammatory affair. Am J Transplant 10:2569–2570. https://doi.org/10.1111/j.1600-6143.2010.03306.x PMID:21114639

 

Weichhart T, Säemann MD. 2010. T helper cell differentiation: understanding the needs of hierarchy. Immunity 32:727–729. https://doi.org/10.1016/j.immuni.2010.06.008 PMID:20620936

 

Säemann MD, Hörl WH, Weichhart T. 2007. Uncovering host defences in the urinary tract: cathelicidin and beyond. Nephrol Dial Transplant 22:347–349. https://doi.org/10.1093/ndt/gfl590 PMID:17035368

 


Books, book chapters

Katholnig K, Poglitsch M, Hengstschläger M, Weichhart T. 2015. Lysis gradient centrifugation: a flexible method for the isolation of nuclei from primary cells. Methods Mol Biol 1228:15–23. https://doi.org/10.1007/978-1-4939-1680-1_2 PMID:25311118

 

Weichhart T. 2012. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol Biol 821:1–14. https://doi.org/10.1007/978-1-61779-430-8_1 PMID:22125056

 

Editor of “mTOR: Methods and Protocols”, Methods in Molecular Biology, Humana Press, 2012. https://link.springer.com/book/10.1007/978-1-61779-430-8